238 related articles for article (PubMed ID: 21209122)
21. Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review.
Wang P; Xu Z
BMC Pulm Med; 2021 Sep; 21(1):279. PubMed ID: 34479523
[TBL] [Abstract][Full Text] [Related]
22.
Kocheva SA; Gjorgjievska M; Martinova K; Antevska-Trajkova Z; Jovanovska A; Plaseska-Karanfilska D
Balkan J Med Genet; 2021 Nov; 24(2):89-93. PubMed ID: 36249522
[TBL] [Abstract][Full Text] [Related]
23. Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility.
Koivuluoma S; Vorimo S; Mattila TM; Tervasmäki A; Kumpula T; Kuismin O; Winqvist R; Moilanen J; Mantere T; Pylkäs K
Fam Cancer; 2023 Jan; 22(1):13-17. PubMed ID: 35590014
[TBL] [Abstract][Full Text] [Related]
24. Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations.
Vulliamy TJ; Kirwan MJ; Beswick R; Hossain U; Baqai C; Ratcliffe A; Marsh J; Walne A; Dokal I
PLoS One; 2011; 6(9):e24383. PubMed ID: 21931702
[TBL] [Abstract][Full Text] [Related]
25. [Dyskeratosis congenita: an update].
Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
[TBL] [Abstract][Full Text] [Related]
26. Dyskeratosis congenita: telomerase, telomeres and anticipation.
Marrone A; Walne A; Dokal I
Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
[TBL] [Abstract][Full Text] [Related]
27. Dyskeratosis congenita, stem cells and telomeres.
Kirwan M; Dokal I
Biochim Biophys Acta; 2009 Apr; 1792(4):371-9. PubMed ID: 19419704
[TBL] [Abstract][Full Text] [Related]
28. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.
Ballew BJ; Yeager M; Jacobs K; Giri N; Boland J; Burdett L; Alter BP; Savage SA
Hum Genet; 2013 Apr; 132(4):473-80. PubMed ID: 23329068
[TBL] [Abstract][Full Text] [Related]
29. The C-Terminal Extension Unique to the Long Isoform of the Shelterin Component TIN2 Enhances Its Interaction with TRF2 in a Phosphorylation- and Dyskeratosis Congenita Cluster-Dependent Fashion.
Nelson ND; Dodson LM; Escudero L; Sukumar AT; Williams CL; Mihalek I; Baldan A; Baird DM; Bertuch AA
Mol Cell Biol; 2018 Jun; 38(12):. PubMed ID: 29581185
[TBL] [Abstract][Full Text] [Related]
30. Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients.
Kirwan M; Beswick R; Vulliamy T; Nathwani AC; Walne AJ; Casimir C; Dokal I
Br J Haematol; 2009 Mar; 144(5):771-81. PubMed ID: 19036115
[TBL] [Abstract][Full Text] [Related]
31. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.
Vulliamy TJ; Knight SW; Mason PJ; Dokal I
Blood Cells Mol Dis; 2001; 27(2):353-7. PubMed ID: 11259155
[TBL] [Abstract][Full Text] [Related]
32. A Truncating Germline Mutation of
He H; Li W; Comiskey DF; Liyanarachchi S; Nieminen TT; Wang Y; DeLap KE; Brock P; de la Chapelle A
Thyroid; 2020 Feb; 30(2):204-213. PubMed ID: 31928178
[No Abstract] [Full Text] [Related]
33. Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood.
Sasa GS; Ribes-Zamora A; Nelson ND; Bertuch AA
Clin Genet; 2012 May; 81(5):470-8. PubMed ID: 21477109
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders.
Balakumaran A; Mishra PJ; Pawelczyk E; Yoshizawa S; Sworder BJ; Cherman N; Kuznetsov SA; Bianco P; Giri N; Savage SA; Merlino G; Dumitriu B; Dunbar CE; Young NS; Alter BP; Robey PG
Blood; 2015 Jan; 125(5):793-802. PubMed ID: 25499762
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Follow-Up of a Case with Dyskeratosis Congenita Caused by NHP2-V126M/X154R Mutation: Genotype-Phenotype Association.
Erdem M; Tüfekçi Ö; Yılmaz Ş; Alacacıoğlu İ; Ören H
Acta Haematol; 2019; 141(1):28-31. PubMed ID: 30472699
[TBL] [Abstract][Full Text] [Related]
36. Dyskeratosis congenita associated with leukoplakia of the tongue.
Noto Z; Tomihara K; Furukawa K; Noguchi M
Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
[TBL] [Abstract][Full Text] [Related]
37. The shelterin complex and hematopoiesis.
Jones M; Bisht K; Savage SA; Nandakumar J; Keegan CE; Maillard I
J Clin Invest; 2016 May; 126(5):1621-9. PubMed ID: 27135879
[TBL] [Abstract][Full Text] [Related]
38. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita.
Du H; Guo Y; Ma D; Tang K; Cai D; Luo Y; Xie C
Medicine (Baltimore); 2018 May; 97(19):e0724. PubMed ID: 29742735
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
[TBL] [Abstract][Full Text] [Related]
40. A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice.
Frescas D; de Lange T
Genes Dev; 2014 Jan; 28(2):153-66. PubMed ID: 24449270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]